Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity PRPH - ProPhase Labs, Inc.
91.9 M
LAST VALUE
1.46%
2 YEAR CAGR
34.69%
5 YEAR CAGR
18.10%
10 YEAR CAGR